| 05/07/2026 3:56 PM | Charles River Laboratories International (1100682) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 05/07/2026 6:14 AM | Charles River Laboratories International (1100682) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/06/2026 2:45 PM | Charles River Laboratories International (1100682) Subject Invesco Ltd. (914208) Filed by | Form SCHEDULE 13G/A | |
| 05/06/2026 10:06 AM | Charles River Laboratories International (1100682) Subject FMR LLC (315066) Filed by | Form SCHEDULE 13G | |
| 05/04/2026 4:16 PM | Charles River Laboratories International (1100682) Issuer Coleman Glenn (1434369) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/29/2026 4:49 PM | Charles River Laboratories International (1100682) Subject VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by | Form SCHEDULE 13G | |
| 04/08/2026 3:53 PM | Charles River Laboratories International (1100682) Issuer Coleman Glenn (1434369) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/31/2026 6:50 AM | Charles River Laboratories International (1100682) Filer | Form DEF 14A | |
| 03/31/2026 6:54 AM | Charles River Laboratories International (1100682) Filer | Form ARS | |
| 03/26/2026 4:15 PM | Charles River Laboratories International (1100682) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/05/2026 4:18 PM | Charles River Laboratories International (1100682) Issuer Girshick Birgit (1732091) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for CRL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Charles River Laboratories International and its competitors with MarketBeat's FREE daily newsletter.
|
| 03/04/2026 3:39 PM | Charles River Laboratories International (1100682) Issuer LaPlume Joseph W (1767215) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 3:42 PM | Charles River Laboratories International (1100682) Issuer FOSTER JAMES C (1141722) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/25/2026 6:34 AM | Charles River Laboratories International (1100682) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/18/2026 3:39 PM | Charles River Laboratories International (1100682) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/18/2026 8:21 AM | Charles River Laboratories International (1100682) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 02/18/2026 6:13 AM | Charles River Laboratories International (1100682) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/12/2026 12:51 PM | Charles River Laboratories International (1100682) Subject Invesco Ltd. (914208) Filed by | Form SCHEDULE 13G | |
| 02/10/2026 10:19 AM | Charles River Laboratories International (1100682) Subject | Form SCHEDULE 13G/A | |
| 02/03/2026 3:36 PM | Charles River Laboratories International (1100682) Issuer LaPlume Joseph W (1767215) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/02/2026 3:39 PM | Charles River Laboratories International (1100682) Issuer Knell Michael Gunnar (1543779) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/02/2026 3:42 PM | Charles River Laboratories International (1100682) Issuer Girshick Birgit (1732091) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/02/2026 3:46 PM | Charles River Laboratories International (1100682) Issuer FOSTER JAMES C (1141722) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/20/2026 7:49 AM | Charles River Laboratories International (1100682) Issuer LaPlume Joseph W (1767215) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/13/2026 7:10 AM | Charles River Laboratories International (1100682) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/09/2026 3:18 PM | Charles River Laboratories International (1100682) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/03/2025 6:28 AM | Charles River Laboratories International (1100682) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/17/2025 7:06 AM | Charles River Laboratories International (1100682) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/12/2025 8:33 AM | Charles River Laboratories International (1100682) Subject WELLINGTON MANAGEMENT GROUP LLP (902219) Filed by | Form SCHEDULE 13G/A | |
| 11/07/2025 3:35 PM | Charles River Laboratories International (1100682) Issuer Knell Michael Gunnar (1543779) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/05/2025 8:12 AM | Charles River Laboratories International (1100682) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/05/2025 6:16 AM | Charles River Laboratories International (1100682) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/19/2025 3:14 PM | Charles River Laboratories International (1100682) Filer | Form 8-K/A | |
| 09/16/2025 6:10 AM | Charles River Laboratories International (1100682) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/22/2025 12:37 PM | Charles River Laboratories International (1100682) Subject LaPlume Joseph W (1767215) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/20/2025 3:45 PM | Charles River Laboratories International (1100682) Issuer LaPlume Joseph W (1767215) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/18/2025 12:27 PM | Charles River Laboratories International (1100682) Subject LaPlume Joseph W (1767215) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/14/2025 4:41 PM | Charles River Laboratories International (1100682) Subject NOMURA HOLDINGS INC (1163653) Filed by | Form SCHEDULE 13G | |
| 08/08/2025 3:18 PM | Charles River Laboratories International (1100682) Issuer LaPlume Joseph W (1767215) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/06/2025 8:07 AM | Charles River Laboratories International (1100682) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/06/2025 6:08 AM | Charles River Laboratories International (1100682) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
| 06/25/2025 3:34 PM | Charles River Laboratories International (1100682) Subject WALLMAN RICHARD F (1198092) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/10/2025 3:22 PM | Charles River Laboratories International (1100682) Issuer Mintz Mark (2071546) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 06/09/2025 3:21 PM | Charles River Laboratories International (1100682) Issuer LaPlume Joseph W (1767215) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/04/2025 3:40 PM | Charles River Laboratories International (1100682) Issuer Graves Paul W (1559551) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/04/2025 3:42 PM | Charles River Laboratories International (1100682) Issuer Enyedy Mark J (1586965) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/04/2025 3:45 PM | Ceesay Abraham (1722140) Reporting Charles River Laboratories International (1100682) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/04/2025 3:38 PM | Barg Steven (1852883) Reporting Charles River Laboratories International (1100682) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/03/2025 3:46 PM | Charles River Laboratories International (1100682) Issuer FOSTER JAMES C (1141722) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/03/2025 3:49 PM | Charles River Laboratories International (1100682) Issuer Creamer Victoria L (1632780) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/03/2025 3:52 PM | Charles River Laboratories International (1100682) Issuer Girshick Birgit (1732091) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/29/2025 4:18 PM | Charles River Laboratories International (1100682) Issuer Graves Paul W (1559551) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 05/29/2025 4:23 PM | Charles River Laboratories International (1100682) Issuer Enyedy Mark J (1586965) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 05/29/2025 4:26 PM | Barg Steven (1852883) Reporting Charles River Laboratories International (1100682) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 05/29/2025 4:29 PM | Ceesay Abraham (1722140) Reporting Charles River Laboratories International (1100682) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 05/29/2025 3:54 PM | Charles River Laboratories International (1100682) Issuer Creamer Victoria L (1632780) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/29/2025 3:58 PM | Charles River Laboratories International (1100682) Issuer Girshick Birgit (1732091) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/23/2025 3:08 PM | Andrews Nancy C (1804999) Reporting Charles River Laboratories International (1100682) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/15/2025 3:38 PM | Charles River Laboratories International (1100682) Issuer LaPlume Joseph W (1767215) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/15/2025 3:41 PM | Charles River Laboratories International (1100682) Issuer MASSARO GEORGE (1221496) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/13/2025 2:33 PM | Charles River Laboratories International (1100682) Subject LaPlume Joseph W (1767215) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/12/2025 9:44 AM | Charles River Laboratories International (1100682) Subject WELLINGTON MANAGEMENT GROUP LLP (902219) Filed by | Form SCHEDULE 13G/A | |